These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 458187)

  • 1. Carcinoembryonic antigen: increased plasma levels in recessive epidermolysis bullosa.
    Rochman H; Cooper M; Esterly NB; Bauer EA
    J Invest Dermatol; 1979 May; 72(5):262-3. PubMed ID: 458187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human skin collagenase in recessive dystrophic epidermolysis bullosa. Purification of a mutant enzyme from fibroblast cultures.
    Stricklin GP; Welgus HG; Bauer EA
    J Clin Invest; 1982 Jun; 69(6):1373-83. PubMed ID: 6282934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood vitamin and trace metal levels in epidermolysis bullosa.
    Fine JD; Tamura T; Johnson L
    Arch Dermatol; 1989 Mar; 125(3):374-9. PubMed ID: 2923444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colchicine-induced modulation of collagenase in human skin fibroblast cultures. II. A probe for defective regulation in epidermolysis bullosa.
    Bauer EA; Valle KJ; Esterly NB
    J Invest Dermatol; 1982 Dec; 79(6):403-7. PubMed ID: 6292310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of elastase-type activity in blister fluids of recessive dystrophic epidermolysis bullosa.
    Francès C; Meimon G; Herson S; Robert L
    Clin Physiol Biochem; 1986; 4(6):350-4. PubMed ID: 3643827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of human skin collagenase in epidermolysis bullosa.
    Bauer EA; Gedde-Dahl T; Eisen AZ
    J Invest Dermatol; 1977 Mar; 68(3):119-24. PubMed ID: 190326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor therapy for recessive dystrophic epidermolysis bullosa. In vitro effect and clinical trial with camostat mesylate.
    Ikeda S; Manabe M; Muramatsu T; Takamori K; Ogawa H
    J Am Acad Dermatol; 1988 Jun; 18(6):1246-52. PubMed ID: 3385039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of plasma and erythrocyte essential fatty acid composition in epidermolysis bullosa: influence of treatment with diphenylhydantoin.
    Cunnane SC; Kent ET; McAdoo KR; Caldwell D; Lin AN; Carter DM
    J Invest Dermatol; 1987 Oct; 89(4):395-9. PubMed ID: 3668282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital pyloric atresia and epidermolysis bullosa letalis in premature siblings.
    Rosenbloom MS; Ratner M
    J Pediatr Surg; 1987 Apr; 22(4):374-6. PubMed ID: 3572700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and gastrointestinal manifestations of epidermolysis bullosa.
    Travis SP; McGrath JA; Turnbull AJ; Schofield OM; Chan O; O'Connor AF; Mayou B; Eady RA; Thompson RP
    Lancet; 1992 Dec 19-26; 340(8834-8835):1505-6. PubMed ID: 1361600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermolysis bullosa simplex: identification of a kindred with autosomal recessive transmission of the Weber-Cockayne variety.
    Fine JD; Johnson L; Wright T; Horiguchi Y
    Pediatr Dermatol; 1989 Mar; 6(1):1-5. PubMed ID: 2539587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The eye in epidermolysis bullosa.
    Tong L; Hodgkins PR; Denyer J; Brosnahan D; Harper J; Russell-Eggitt I; Taylor DS; Atherton D
    Br J Ophthalmol; 1999 Mar; 83(3):323-6. PubMed ID: 10365041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Autosomal recessive albopapuloid dystrophic epidermolysis bullosa].
    Ramelet AA; Boillat C
    Dermatologica; 1985; 171(6):397-406. PubMed ID: 4092794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)].
    Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I
    Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral soft tissues in hereditary epidermolysis bullosa.
    Wright JT; Fine JD; Johnson LB
    Oral Surg Oral Med Oral Pathol; 1991 Apr; 71(4):440-6. PubMed ID: 2052329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of epidermolysis bullosa in Scotland.
    Horn HM; Priestley GC; Eady RA; Tidman MJ
    Br J Dermatol; 1997 Apr; 136(4):560-4. PubMed ID: 9155958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autosomal recessive epidermolysis bullosa simplex. Generalized phenotypic features suggestive of junctional or dystrophic epidermolysis bullosa, and association with neuromuscular diseases.
    Fine JD; Stenn J; Johnson L; Wright T; Bock HG; Horiguchi Y
    Arch Dermatol; 1989 Jul; 125(7):931-8. PubMed ID: 2662909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dental caries risk in hereditary epidermolysis bullosa.
    Wright JT; Fine JD; Johnson L
    Pediatr Dent; 1994; 16(6):427-32. PubMed ID: 7854950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolysis bullosa in the eastern province of Saudi Arabia.
    Abahussein AA; al-Zayir AA; Mostafa WZ; Okoro AN
    Int J Dermatol; 1993 Aug; 32(8):579-81. PubMed ID: 8407073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.